{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:08:57Z","timestamp":1783055337090,"version":"3.54.6"},"reference-count":56,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2003,8,11]],"date-time":"2003-08-11T00:00:00Z","timestamp":1060560000000},"content-version":"vor","delay-in-days":41,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2003,7]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Die Psoriasis ist eine chronisch entz\u00fcndliche Erkrankung der Haut und Gelenke. Die Entstehung einer Psoriasis unterliegt zahlreichen Einfl\u00fcssen. Zu den am besten charakterisierten Faktoren geh\u00f6ren bestimmte genetische Merkmale wie Histokompatibilit\u00e4tsantigene und sogenannte Psoriasis Suszeptibilit\u00e4tsgene, sowie Triggerfaktoren, die eine Psoriasis ausl\u00f6sen oder ihren Verlauf verschlechtern k\u00f6nnen. Aus pathophysiologischer Sicht wird die Psoriasis heute \u00fcberwiegend als eine durch T\u2010Lymphozyten vermittelte Autoimmunerkrankung angesehen, deren Autoantigen bis heute nicht bekannt ist. Diskutiert werden bakterielle Proteine mit Struktur\u00e4hnlichkeit zu Keratinozytenproteinen. \u00c4hnlich wie bei der Manifestation von Erkrankungssch\u00fcben anderer Autoimmunerkrankungen stehen Entz\u00fcndungsmediatoren des angeborenen Immunsystems am Anfang einer Kaskade, die sowohl lokal in der Haut als auch generalisiert im Immunsystem eine Entz\u00fcndungsreaktion hervorrufen. Eine zentrale Rolle nehmen IFN\u2010\u03b3 produzierende CD4<jats:sup>+<\/jats:sup> T\u2010Lymphozyten, die Th1\u2010Lymphozyten ein, die durch direkte und indirekte Interaktionen mit Antigenpr\u00e4sentierenden Zellen, Mastzellen, Neutrophilen Granulozyten und Endothelzellen f\u00fcr die Entstehung der Psoriasis verantwortlich sind. Diese Entz\u00fcndungskaskade provoziert in der Haut gleichzeitig eine ausgepr\u00e4gte Gef\u00e4\u00dfneubildung und die Keratinozytenproliferation. Eine Vielzahl von Rezeptoren und Mediatoren sind in dieses Netzwerk involviert. Neue Therapieans\u00e4tze mit Zytokinen oder Zytokinantik\u00f6rpern zielen entweder darauf ab, diese \u00fcberschie\u00dfende Immunantwort zu hemmen, oder darauf spezifisch die sch\u00e4dliche, gegen die Haut gerichtete Immunantwort, in einen sch\u00fctzenden Ph\u00e4notyp mit anti\u2010entz\u00fcndlichen Eigenschaften zu \u00fcberf\u00fchren.<\/jats:p>","DOI":"10.1046\/j.1610-0387.2003.03010.x","type":"journal-article","created":{"date-parts":[[2003,8,11]],"date-time":"2003-08-11T09:18:51Z","timestamp":1060593531000},"page":"524-532","source":"Crossref","is-referenced-by-count":8,"title":["Immunpathogenese der Psoriasis"],"prefix":"10.1111","volume":"1","author":[{"given":"Kamran","family":"Ghoreschi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"R\u00f6cken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,8,11]]},"reference":[{"key":"e_1_2_12_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2001.00832.x"},{"key":"e_1_2_12_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2001.00830.x"},{"key":"e_1_2_12_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-4857-7_32"},{"key":"e_1_2_12_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(09)80161-8"},{"key":"e_1_2_12_6_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200001030-00003"},{"key":"e_1_2_12_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2000.00655-4.x"},{"key":"e_1_2_12_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2001.00834.x"},{"key":"e_1_2_12_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2000.00588.x"},{"key":"e_1_2_12_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(95)80132-4"},{"key":"e_1_2_12_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2001.00831.x"},{"key":"e_1_2_12_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.39.10.767"},{"key":"e_1_2_12_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04504.x"},{"key":"e_1_2_12_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1470.2001.018003188.x"},{"key":"e_1_2_12_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-200207000-00005"},{"key":"e_1_2_12_16_2","first-page":"973","article-title":"MICA rather than MICB, TNFA, or HLA\u2010DRB1 is associated with susceptibility to psoriatic arthritis","volume":"29","author":"Gonzalez S","year":"2002","journal-title":"J Rheumatol"},{"key":"e_1_2_12_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0022-202x.2001.01656.x"},{"key":"e_1_2_12_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12523566"},{"key":"e_1_2_12_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(96)00562-2"},{"key":"e_1_2_12_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(98)00019-X"},{"key":"e_1_2_12_21_2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2340\/0001555576357360","article-title":"Soluble interleukin\u20102 receptor (sIL\u20102R) is a marker of disease activity in psoriasis: a comparison of sIL\u20102R, sCD27, sCD4, sCD8 and sICAM\u20101","volume":"76","author":"De Rie MA","year":"1996","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_12_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2003.00647.x"},{"key":"e_1_2_12_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)00178-1"},{"key":"e_1_2_12_24_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.4.2240"},{"key":"e_1_2_12_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.140S54001.x"},{"key":"e_1_2_12_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197909063011015"},{"key":"e_1_2_12_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2003.01221.x"},{"key":"e_1_2_12_28_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.107945"},{"key":"e_1_2_12_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)80200-2"},{"key":"e_1_2_12_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0595-442"},{"key":"e_1_2_12_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10169"},{"key":"e_1_2_12_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1997.17821869.x"},{"key":"e_1_2_12_33_2","doi-asserted-by":"crossref","unstructured":"Austin LM Ozawa M Kikuchi T Walters IB Krueger JG: The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines interferon\u2010gamma interleukin\u20102 and tumor necrosis factor\u2010alpha defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 1999; 113: 752\u200a\u2013\u200a759.","DOI":"10.1046\/j.1523-1747.1999.00749.x"},{"key":"e_1_2_12_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0022-202x.2001.01548.x"},{"key":"e_1_2_12_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0297-183"},{"key":"e_1_2_12_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65109-7"},{"key":"e_1_2_12_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02760.x"},{"key":"e_1_2_12_38_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.10.1441"},{"key":"e_1_2_12_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2001.01262.x"},{"key":"e_1_2_12_40_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117308"},{"key":"e_1_2_12_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.03205.x"},{"key":"e_1_2_12_42_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1087-0024.2000.00006.x"},{"key":"e_1_2_12_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004030050268"},{"key":"e_1_2_12_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/359079a0"},{"key":"e_1_2_12_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(96)80556-1"},{"key":"e_1_2_12_46_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1610-0387.2003.t01-1-02024.x"},{"key":"e_1_2_12_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-003-0497-2"},{"key":"e_1_2_12_48_2","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2002.33078"},{"key":"e_1_2_12_49_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.5.1655"},{"key":"e_1_2_12_50_2","first-page":"1515","article-title":"Eradication of disseminated lymphomas with CpG\u2010DNA activated T helper type 1 cells from nontransgenic mice","volume":"60","author":"Egeter O","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_12_51_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1990.01670270083013"},{"key":"e_1_2_12_52_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00444.x"},{"key":"e_1_2_12_53_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1476"},{"key":"e_1_2_12_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04954-0"},{"key":"e_1_2_12_55_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar552"},{"key":"e_1_2_12_56_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI6910"},{"key":"e_1_2_12_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm804"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1610-0387.2003.03010.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1610-0387.2003.03010.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T12:54:52Z","timestamp":1697201692000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1610-0387.2003.03010.x"}},"subtitle":["Immunopathogenesis of Psoriasis"],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["10.1046\/j.1610-0387.2003.03010.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1610-0387.2003.03010.x","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7]]}}}